Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons
about
Erythropoietin and diabetes mellitusDysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.Diabetes mellitus: channeling care through cellular discoveryErythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke.General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apneaNovel avenues of drug discovery and biomarkers for diabetes mellitus.Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats.Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.Erythropoietin in brain development and beyond.Peroxisome proliferator-activated receptors γ/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus.Regeneration in the nervous system with erythropoietinErythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain.Intranasal erythropoietin therapy in nervous system disorders.Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.Neuronal control of breathing: sex and stress hormones.The Insect Ortholog of the Human Orphan Cytokine Receptor CRLF3 Is a Neuroprotective Erythropoietin Receptor.Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.Neurotrophic paths in the treatment of depression.Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish.Locus Coeruleus Dysfunction in Transgenic Rats with Low Brain Angiotensinogen.Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative.An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models.Alternative Erythropoietin Receptors in the Nervous System.Selective expression of a constitutively active erythropoietin receptor in GABAergic neurons alters hippocampal network properties without affecting cognition.Therapeutic time window for the effects of erythropoietin on astrogliosis and neurite outgrowth in an in vitro model of spinal cord injury.Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil.
P2860
Q26777878-123836C8-2D07-4FE6-BFE6-846971B284C1Q33506633-571826F5-579B-478C-BA68-57EBBDF64CB6Q33749358-16E4F427-88D2-448F-ACC6-7C31D86DC63BQ33787770-B0136803-F313-424C-A3A4-0BE158A9EC05Q34117531-DC4D5431-CA09-465E-B6B6-478E64175294Q34325029-10CA3AF6-9B31-48C6-AABC-4064FA84AE11Q34552287-ADB9DA87-5910-4AAB-B9CD-4542B8FB2FDDQ34558891-D3C5DE11-B1AB-488C-B990-3FE89E61FDCBQ35440761-1736116E-1957-4A2E-ABFB-F511E331644EQ35677223-F6F8B315-2F74-4B26-B92C-BF7A1F6EE598Q35891811-DB0E44AC-F0D9-4BF5-BAF1-3A53718B502BQ35909929-475AD8F7-8D24-4FDB-A468-627182092AF9Q36241486-DAC93CA6-242F-4C2E-B76A-75168CB7CB55Q36247651-4A1AD682-9F88-4167-AE51-AC1A5ADD52B7Q37496924-618D37AC-9874-4493-9AF2-F8BE25CC8DB5Q37817069-8F63B5B8-A89A-4B5A-9182-9DA2C54A9F7AQ37818329-204EB93C-F927-498E-A6A8-DDBA51CE735BQ37901051-B8BB4505-549A-4251-B596-A2191389115DQ38111735-52146945-DA38-42CB-9FCC-C463C40B8C22Q38645702-154F19C9-06B7-4A81-B4B0-B27BD4FEC21CQ38751058-D8B0142F-1C41-4055-B87D-5C5786E2117FQ41660890-BC247182-F6CF-4065-AF67-F0DE6FF1CA79Q42575451-BF4E4DF5-EA8F-4524-A91A-58035BFECCACQ42729265-AB249431-2E7C-4D20-ABC2-4951C08087E1Q42790208-FE7D39EA-09E7-4F01-92E1-A5C8F675A28DQ44363046-1F19BBCA-67E4-4178-BD57-4224BF0E0FFBQ47333139-3E6875D4-D9FA-497D-BD9F-6E20C305CAC7Q47898207-DDB75968-96FC-4E49-B28C-5F90D9703C95Q48409935-620D0EEB-F774-4AD7-8D97-5BB135222C37Q48497465-07C78110-B773-4F42-937C-C48DE0E26F42Q48833407-EF2B5A7F-4B0C-4618-80FC-4E0206681DC0Q49375977-EC0FA25A-9446-4A52-9C3A-7146A12E5C64Q52145795-EDD34B2C-F3D6-43E9-8865-7A860BE821DDQ54123946-88F7A3A5-34C3-42D5-A5F1-EAE775773444Q55717768-C0C45EBE-9E2C-417D-B0C8-742C0DF1072F
P2860
Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons
description
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2009
@ast
im Juni 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/06/16)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/06/16)
@nl
наукова стаття, опублікована в червні 2009
@uk
name
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@ast
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@en
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@nl
type
label
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@ast
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@en
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@nl
prefLabel
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@ast
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@en
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@nl
P2093
P2860
P356
P1476
Optimal neuroprotection by ery ...... ion of its receptor in neurons
@en
P2093
Amor Belmeguenai
Anne Morales
Béatrice Georges
Chantal Bonnet
Colette Moulin
Etienne-Emile Baulieu
Jacques Bodennec
Jean-Jacques Risso
Jean-Marc Pequignot
Laurent Bezin
P2860
P304
P356
10.1073/PNAS.0901840106
P407
P577
2009-06-16T00:00:00Z